The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease
- 11 March 2003
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 17 (2), 71-97
- https://doi.org/10.1016/s0268-960x(02)00075-9
Abstract
No abstract availableKeywords
This publication has 231 references indexed in Scilit:
- Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear BodiesMolecular and Cellular Biology, 2002
- SUMO: of branched proteins and nuclear bodiesOncogene, 2001
- STATs in oncogenesisOncogene, 2000
- RING domains: master builders of molecular scaffolds?Journal of Molecular Biology, 2000
- Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin AOncogene, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemiaNature Genetics, 1997
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signallingNature, 1992